Quantcast
Home > Quotes > FCSC

Fibrocell Science Inc. Common Stock (FCSC) Quote & Summary Data

FCSC 
$1.875
*  
0.035
1.9%
Get FCSC Alerts
*Delayed - data as of May 24, 2019  -  Find a broker to begin trading FCSC now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
16
Today's High / Low
$ 1.90 / $ 1.80
Share Volume
42,678
50 Day Avg. Daily Volume
1,196,742
Previous Close
$ 1.84
52 Week High / Low
$ 5.17 / $ 1.45
Market Cap
18,296,873
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
0.55

Intraday Chart

Shares Traded

Share Volume:
42,678
50 Day Avg. Daily Volume:
1,196,742

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -1.31

Trading Range

The current last sale of $1.875 is 29.31% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 1.90 $ 5.17
 Low: $ 1.80 $ 1.45

Company Description (as filed with the SEC)

We are an autologous cell and gene therapy company focused on translating personalized biologics into medical breakthroughs for diseases affecting the skin and connective tissue. Our distinctive approach to personalized biologics is based on our proprietary autologous fibroblast technology. Fibroblasts are the most common cell in skin and connective tissue and are responsible for synthesizing extracellular matrix proteins, including collagen and other growth factors, that provide structure and support. Because fibroblasts naturally reside in the localized environment of the skin and connective tissue, they represent an ideal delivery vehicle for proteins targeted to these areas. We target the underlying cause of disease by using fibroblast cells from a patient's skin and genetically modifying them to create localized therapies that are compatible with the unique biology of the patient (i.e., which are autologous).  ... More ...  



Risk Grade

Where does FCSC fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 1.80
Open Date:
May 24, 2019
Close Price:
$ 1.87
Close Date:
May 24, 2019


Consensus Recommendation

Analyst Info